Muna Therapeutics, born from Aarhus University, innovates to halt neurodegenerative diseases like Alzheimer's and Parkinson's. Their mission is to develop drugs that preserve brain function and combat disease progression, addressing a critical global need for over 200 million patients. Their strategy harnesses genetics, bioinformatics, and cell biology to create treatments aimed at reducing neuroinflammation and improving brain resilience.
Established in 2020.
